CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
about
Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse.
P2860
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@ast
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@en
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@nl
type
label
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@ast
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@en
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@nl
prefLabel
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@ast
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@en
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@nl
P2093
P2860
P3181
P356
P1476
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
@en
P2093
Christian Lehmann
Hyewon Yang
Ian Burkovskiy
Joel Sardinha
P2860
P3181
P356
10.3389/FPHAR.2016.00264
P407
P50
P577
2016-08-22T00:00:00Z